Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02036970
Recruitment Status : Completed
First Posted : January 15, 2014
Last Update Posted : January 3, 2019
Information provided by (Responsible Party):
Reata Pharmaceuticals, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 19, 2018
  Actual Study Completion Date : May 16, 2018
  Certification/Extension First Submitted : January 2, 2019